Unusual case of bowel infarction with invasive aspergillus in an immunocompromised patient

Annals of the Academy of Medicine Singapore

Volumn 32, Issue 1, 2003, Pages 122-125

  Tay, Miah Hiang ^a   Balram, C ^a   Foo, K F ^a   Busmanis, I ^b   Raman, S ^b   Khoo, K S ^a  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Capecitabine; Chemotherapy; Docetaxel; Doxorubicin; Neutropenia

Indexed keywords

CAPECITABINE; DOCETAXEL; DOXORUBICIN;

ADULT; ARTICLE; ASPERGILLOSIS; BREAST CARCINOMA; CANDIDA KRUSEI; CASE REPORT; CLINICAL FEATURE; COLON RESECTION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SAFETY; ESCHERICHIA COLI; FEMALE; HUMAN; IMMUNE DEFICIENCY; INTESTINE INFARCTION; NEUTROPENIA; NONHUMAN; SEPSIS;

EID: 0344406220     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Sapunar F, Smith I E. Neoadjuvant chemotherapy for breast cancer. Ann Med 2000; 32:43-50.
2. Gerson S L, Talbot G H, Hurwitz S, Strom B L, Lusk E J, Cassileth P A. Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukaemia. Ann Intern Med, 1984; 100:345-51.
3. Cohen M S, Isturiz R E, Malech H L, Root R K, Wilfert C M, Gutman L, et al. Fungal infection in chronic granulomatous disease: the importance of phagocyte in defense against fungi. Am J Med 1981; 71:59-66.
4. Ibrahim N K, Sahin A A, Dubrow R A, Lynch P M, Boehnke-Michaud L, Valero V, et al. Colitis associated with docetaxel-based chemotherapy in patients with metastatic breast cancer. Lancet 2000; 355:281-3.
5. Muthalib A, Wang C H, Luna G, Ismail F, Li W L, Yoon S S, et al. Combination of taxotere and doxorubicin: An Asian phase II study in first line treatment of metastatic breast cancer. Proceedings of the 36th Annual Meeting of the American Society of Clinical Oncology; 2000 May 20-23. New Orleans, Louisiana. USA: American Society of Clinical Oncology, 2000:abstract no. 473.
6. Kinland D. Aspergillosis. In: Willis Hurst J, editor, Medicine for the Practising Physician. 4th ed. Stamford, Conn: Appleton & Lange Press, 1996:411.
7. Young R C, Bennett J E, Vogel C L, Carbone P P, DeVita V T. Aspergillosis. The spectrum of disease in 98 patients. Medicine (Baltimore) 1970; 49:147-73.
8. Catalano L, Picardi M, Anzivino D, Insabato L, Notaro R, Rotoli B. Small bowel infarction by Aspergillus. Haematologica 1997: 82:182-3.
9. Denning D W. Therapeutic outcome in invasive aspergillosis. Clin Infect Dis 1996; 23:608-15.
10. Denning D W, Stevens D A. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev Infect Dis 1990; 12:1147-201.
11. Fisher B D, Armstrong D, Yu B, Gold J W. Invasive aspergillosis. Progress in early diagnosis and treatment. Am J Med 1981; 71:571-7.